Leah B Stark, OT | |
777 Bannock St, Denver, CO 80204-4507 | |
(303) 436-4949 | |
Not Available |
Full Name | Leah B Stark |
---|---|
Gender | Female |
Speciality | Occupational Therapist |
Location | 777 Bannock St, Denver, Colorado |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1205128063 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225X00000X | Occupational Therapist | 1529 (Colorado) | Primary |
Mailing Address | Practice Location Address |
---|---|
Leah B Stark, OT 777 Bannock St, Mc 7782, Denver, CO 80204-4507 Ph: (720) 956-2394 | Leah B Stark, OT 777 Bannock St, Denver, CO 80204-4507 Ph: (303) 436-4949 |
News Archive
The Cleveland Clinic is launching a Center for Space Medicine that will coordinate its efforts to research medical problems experienced by humans during long-term space flight. The center will work closely with engineers and scientists at Cleveland's NASA Glenn Research Center.
Onyx Pharmaceuticals, Inc. today announced nearly 20 presentations evaluating carfilzomib and ONX 0803 (SB 1518) in hematological cancers at the 51st American Society of Hematology (ASH) Annual Meeting December 5-8, 2009 in New Orleans, LA. Among the data presentations are four oral and seven poster presentations highlighting data from the carfilzomib development program in patients with relapsed and refractory multiple myeloma.
Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has signed an agreement with Tibotec Pharmaceuticals for a non-exclusive license to manufacture, market and distribute a generic version of the non-nucleoside reverse transcriptase inhibitor Rilpivirine Hydrochloride (TMC278), pending its regulatory approval for the treatment of treatment-naive HIV-1-infected adults.
Pfizer Inc. today announced that Quillivant XR (methylphenidate hydrochloride) CII for extended-release oral suspension is now available in the U.S. for the treatment of attention deficit hyperactivity disorder (ADHD).
Given that epilepsy impacts more than 2 million Americans, there is a pressing need for new therapies to prevent this disabling neurological disorder. New findings from the neuroscience laboratory of Mark S. Shapiro, Ph.D., at The University of Texas Health Science Center at San Antonio, published Dec. 20 in the high-impact scientific journal, Neuron, may provide hope.
› Verified 4 days ago
Kristin Turner, OTR Occupational Therapist Medicare: Medicare Enrolled Practice Location: 3105 W Arkansas Ave, Denver, CO 80219 Phone: 303-936-3497 | |
American Council For Th Eblind And Visually Impaired Of Colorado Acbco Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 910 16th St Ste 1240, Denver, CO 80202 Phone: 303-831-0117 Fax: 303-454-3378 | |
Ana Nicole Miller, OTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 2979 Uinta St, Denver, CO 80238 Phone: 720-787-7800 | |
Melanie Marie Shovlin, MS, OTR Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 1460 S Saint Paul St, Denver, CO 80210 Phone: 303-550-5868 | |
Kristen Dorighi, MS, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1667 S Lafayette St, Denver, CO 80210 Phone: 303-715-4482 | |
Sarah Whitaker, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 6060 E Iliff Ave, Denver, CO 80222 Phone: 303-759-4221 | |
Julie Brahen, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2201 N Downing St, Denver, CO 80205 Phone: 303-861-4825 |